Latest News

Experimental antibody shows early promise for treatment of childhood tumor

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody. Four patients are still alive after more than two-and-a-half years and without additional treatment. Neuroblastoma is a cancer of the sympathetic nervous system. It is the most common cancer diagnosed in the first year of life and accounts for 7 to 10 percent of childhood cancers.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Motivation explains disconnect between testing, real-life functioning for seniors

  • Novel technologies advance brain surgery to benefit patients

  • Mutated gene linked to both autism, intellectual disability

  • New concerns over top-selling blood thinning drug after investigation

  • Immune response may cause harm in brain injuries, disorders

  • New mechanism for neurodegeneration found

  • New tools help neuroscientists analyze 'big data'

  • Six new genetic risk factors for Parkinson's found

  • CEOs who motivate with 'fightin' words' shoot themselves in the foot

  • Knowledgeable consumers more likely to buy when given fewer options

  •